XNAS
POCI
Market cap38mUSD
Jul 10, Last price
4.98USD
1D
3.56%
1Q
18.71%
Jan 2017
738.98%
Name
Precision Optics Corporation Inc
Chart & Performance
P/E
—
P/S
2.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.40%
Rev. gr., 5y
13.98%
Revenues
19m
-0.07%
Net income
-6m
L+95.85%
CFO
-4m
L+32.22%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Precision Optics Corporation, Inc. focuses on the engineering, manufacturing, and commercialization of sophisticated optical and lighting systems, alongside their related constituent parts. The company primarily serves markets within the United States and the European Economic Area. Its product portfolio includes medical instruments like endoscopes and endocouplers, in addition to tailored imaging and illumination solutions such as high-precision miniature lenses, micro medical cameras, and specialized 3D endoscopes. These offerings are designed for minimally invasive surgical procedures, utilized by healthcare facilities and medical professionals. Furthermore, Precision Optics supplies various components and assemblies for both industrial and defense sectors. The firm distributes its medical products to other medical device manufacturers. Established in 1982, Precision Optics Corporation, Inc. is headquartered in Gardner, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||